Key Highlights

  • Teradyne declined 10.16% as semiconductor test equipment — a capital expenditure category that lags chipmaking capacity investment by one to two quarters — faced selling pressure on expectations that any moderation in advanced chip production, signalled by SK Hynix's production pivot, will compress near-term test equipment orders.
  • Teradyne's robotics division (Universal Robots) provides partial revenue diversification from pure semiconductor test exposure, but the company's stock performance remains closely correlated to semiconductor capex cycle sentiment, making it a natural casualty of the June 23 broader chipmaking selloff.

Teradyne (NASDAQ: TER) fell 10.16% on June 23, 2026, in a decline that illustrates how far into the semiconductor supply chain the day's AI capex anxiety propagated. Teradyne does not manufacture chips. It makes the automated test equipment (ATE) that chipmakers use to verify that semiconductor devices function correctly before shipment — a step that is indispensable in any production process but whose demand is structurally downstream of chipmaking capacity decisions.

This positioning makes Teradyne a second-derivative play on semiconductor capex. When chipmakers expand capacity — as they did aggressively in 2024 and 2025 in response to AI demand — ATE orders follow with a one-to-two quarter lag. When chipmakers slow capacity expansion — as SK Hynix's June 23 announcement suggested may be occurring in advanced AI memory — ATE order books feel the pressure before the capacity reduction is complete. The market, anticipating this sequence, sold Teradyne in advance of any actual order commentary.

Teradyne's core semiconductor test business serves memory chipmakers, mobile SoC manufacturers, and data centre chip producers — all three of which faced headwinds on June 23. The company's System Test division, which tests storage and compute systems, and its Wireless Test division both provide modest diversification, but the majority of revenue and earnings growth is tied to the advanced semiconductor test cycle.

The robotics segment — Universal Robots, the collaborative robot arm business acquired in 2015 — adds a layer of revenue that is independent of semiconductor dynamics. Universal Robots serves industrial automation customers across automotive, electronics assembly, and general manufacturing. In a session driven by semiconductor-specific concerns, this diversification provides limited share price protection because investors who are selling Teradyne are primarily selling semiconductor cycle exposure, and the robotics segment is not large enough to fundamentally recharacterise the company's earnings profile.

At a market capitalisation of 64.27 billion USD, Teradyne is mid-sized by semiconductor equipment standards. Its valuation multiple had expanded significantly on the AI infrastructure theme, and multiple expansion during a positive cycle invariably produces multiple contraction during a negative one.

The relevant question for investors post-June 23 is whether the SK Hynix production shift represents a temporary rebalancing between product categories or a structural moderation in advanced AI chip demand. If the former, Teradyne's order pipeline will stabilise. If the latter, the 10.16% decline may understate the earnings revision risk embedded in current consensus estimates.